Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1776)
  2. Journal Article (1579)
  3. Review (119)
  4. Research Letter (54)
  5. Editorial (46)
  6. Book Section (39)
  7. Guidelines (19)
  8. Conference Paper (18)
  9. Correspondence (12)
  10. Miscellaneous (2)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3665)
  2. Department of Medicine (3634)
  3. Hematologic Malignancies, Division of (3630)
  4. GSK Faculty (1770)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1368)
  6. Executive Committee, Center for Hematologic Malignancies (963)

More Groups

People
  1. Ross Levine (781)
  2. Martin Tallman (651)
  3. David Scheinberg (499)
  4. Jae Park (365)
  5. Eytan Stein (360)
  6. Raajit Rampal (346)

More People

Years
  1. 2025 (61)
  2. 2024 (183)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1239)
  2. Journal of Clinical Oncology (215)
  3. Clinical Lymphoma, Myeloma and Leukemia (116)
  4. Leukemia (109)
  5. Haematologica (106)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1328)
  2. Nature Publishing Group (319)
  3. Elsevier Inc. (256)
  4. American Association for Cancer Research (233)
  5. American Society of Clinical Oncology (227)
  6. Ferrata Storti Foundation (106)

More Publishers

Results (3665)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: A practical guide to diagnosis and management
    Review

    Tremblay, D.; Hasserjian, R. P.; Rampal, R. K.
    Leukemia (2025)

    Fulltext@MSK | Save
  • Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias
    Journal Article

    Kim, W. J.; Crosse, E. I.; De Neef, E.; Etxeberria, I.; Sabio, E. Y.; Wang, E.; Bewersdorf, J. P.; Lin, K. T.; Lu, S. X.; Belleville, A.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies
    Journal Article

    Mosialou, I.; Ali, A. M.; Labella, R.; Bisikirska, B.; Cuesta-Dominguez, A.; Vgenopoulou, P.; Reyes, I.; Rao, S. M.; Wang, A.; Luo, N.; more...
    Cancer Cell (2025)

    Fulltext@MSK | Save
  • Azacitidine, venetoclax, and revumenib for newly diagnosed NPM1-mutated or KMT2A-rearranged AML
    Journal Article

    Zeidner, J. F.; Lin, T. L.; Welkie, R. L.; Curran, E.; Koenig, K.; Stock, W.; Madanat, Y. F.; Swords, R.; Baer, M. R.; Blum, W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Barriers to chimeric antigen receptor T-cell therapy
    Research Letter

    Valtis, Y. K.; Chin, K. K.; Nemirovsky, D.; Devlin, S. M.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
    Journal Article

    Sirenko, M.; Lee, S.; Sun, Z.; Chaligne, R.; Loghavi, S.; Asimomitis, G.; Brierley, C. K.; Bernard, E.; Cai, S. F.; Myers, R. M.; more...
    Cell Stem Cell (2025)

    Fulltext@MSK | Save
  • Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML
    Journal Article

    Wang, Z.; Skwarska, A.; Poigaialwar, G.; Chaudhry, S.; Rodriguez-Meira, A.; Sui, P.; Olivier, E.; Jia, Y.; Gupta, V.; Fiskus, W.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • A phase I study of FHD-286, a dual BRG1/BRM (SMARCA4/SMARCA2) inhibitor, in patients with advanced myeloid malignancies
    Journal Article

    DiNardo, C. D.; Fathi, A. T.; Kishtagari, A.; Bhalla, K. N.; Quintás-Cardama, A.; Reilly, S. A.; Almon, C.; Patriquin, C.; Nabhan, S.; Healy, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Identifying people with acute lymphoblastic leukemia who are most suitable for treatment with inotuzumab ozogamicin: A plain language summary
    Review

    Marks, D. I.; Cassaday, R. D.; Ribera, J. M.; Schuh, A. C.; Park, J. H.; Chiaretti, S.; Stelljes, M.
    Expert Review of Hematology (2025)

    Fulltext@MSK | Save
  • Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: A randomized phase 3 trial
    Journal Article

    Rampal, R. K.; Grosicki, S.; Chraniuk, D.; Abruzzese, E.; Bose, P.; Gerds, A. T.; Vannucchi, A. M.; Palandri, F.; Lee, S. E.; Gupta, V.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save